Holen Sie sich die Stockscreener-App
30.94
7.92%
2.27
Vorhandelsmarkt:
30.70
-0.24
-0.78%
Cg Oncology Inc Aktie (CGON) Neueste Nachrichten
Can CG Oncology Inc. withstand a market correctionJuly 2025 Rallies & Fast Moving Stock Trade Plans - khodrobank.com
Chart based exit strategy for CG Oncology Inc.Weekly Loss Report & Verified Momentum Watchlists - Newser
Detecting support and resistance levels for CG Oncology Inc.July 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
Song Hong Fang, CG Oncology director, sells $2.78m in shares - Investing.com
CG Oncology Directors Sell Shares, Buy Others Amid Market Volatility. - AInvest
How does CG Oncology Inc. score in quality rankingsWeekly Risk Report & AI Powered Buy/Sell Recommendations - khodrobank.com
Understanding CG Oncology Inc.’s price movementM&A Rumor & Low Volatility Stock Suggestions - Newser
Can CG Oncology Inc. deliver alphaJuly 2025 Levels & Capital Protection Trading Alerts - khodrobank.com
What moving averages say about CG Oncology Inc.July 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
Will CG Oncology Inc. stock go up soonShort Setup & Real-Time Volume Triggers - Newser
Real time breakdown of CG Oncology Inc. stock performance - Newser
CG Oncology Inc. stock chart pattern explained2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
Ani Pharmaceuticals shares rise 1.98% after-hours following CG Oncology's PIVOT-006 study enrollment completion. - AInvest
Will CG Oncology Inc. benefit from macro trendsSwing Trade & Accurate Intraday Trading Signals - Newser
CG Oncology Completes Enrollment for Phase 3 Study - Orange County Business Journal
CG Oncology completes enrollment for bladder cancer therapy trial - Investing.com
CG Oncology completes enrollment in PIVOT-006 - TipRanks
CG Oncology Completes Rapid Enrollment in Phase 3 Study for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - Quiver Quantitative
CG Oncology Completes Enrollment in PIVOT-006 Trial for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - AInvest
Largest-Ever Trial: 360 Patients Join CG Oncology's Breakthrough Bladder Cancer Study One Year Early - Stock Titan
Using economic indicators to assess CG Oncology Inc. potentialMarket Activity Recap & Entry Point Confirmation Signals - Newser
Real time alert setup for CG Oncology Inc. performanceJuly 2025 Momentum & Daily Profit Focused Screening - Newser
Developing predictive dashboards with CG Oncology Inc. data2025 Retail Activity & Real-Time Volume Triggers - Newser
What are CG Oncology Inc.’s technical support levels2025 Volatility Report & Risk Managed Trade Strategies - khodrobank.com
How to build a custom watchlist for CG Oncology Inc.Market Movement Recap & Community Supported Trade Ideas - Newser
Analyzing CG Oncology Inc. with risk reward ratio chartsTrade Performance Summary & AI Powered Buy/Sell Recommendations - Newser
Will CG Oncology Inc. outperform the marketWall Street Watch & Intraday High Probability Alerts - Newser
Should you hold or exit CG Oncology Inc. nowEntry Point & Free Verified High Yield Trade Plans - Newser
Published on: 2025-09-03 00:18:12 - Newser
Can CG Oncology Inc. sustain earnings growthWeekly Earnings Recap & Long-Term Safe Investment Plans - khodrobank.com
Is CG Oncology Inc. stock reversal real or fakeBear Alert & Low Risk High Reward Trade Ideas - Newser
Technical signs of recovery in CG Oncology Inc.Quarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - Newser
Using flow based indicators on CG Oncology Inc.2025 Price Momentum & Consistent Growth Stock Picks - Newser
Is CG Oncology Inc. still worth holding after the dipQuarterly Performance Summary & Verified Chart Pattern Trade Signals - Newser
Is CG Oncology Inc. a candidate for recovery playJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
Visualizing CG Oncology Inc. stock with heatmapsNew Guidance & Smart Money Movement Alerts - Newser
CG Oncology Inc. stock trend forecastForecast Cut & AI Driven Stock Movement Reports - Newser
Can CG Oncology Inc. hit a new high this monthTrade Entry Summary & Low Risk Entry Point Tips - Newser
Chart based analysis of CG Oncology Inc. trendsJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
What is the target price for CG Oncology Inc. stockJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - khodrobank.com
Risk adjusted return profile for CG Oncology Inc. analyzedWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser
Non Muscle Invasive Bladder Cancer Pipeline Insight Report 2025: Emerging Therapies and Treatment Advances - AInvest
How CG Oncology Inc. stock performs during market volatilityDividend Hike & AI Forecast for Swing Trade Picks - Newser
How cyclical is CG Oncology Inc.’s revenue streamQuarterly Trade Review & Reliable Breakout Stock Forecasts - khodrobank.com
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):